IMPACT OF GLAUCOMA ON THE DEVELOPMENT OF BLINDNESS IN PATIENTS WITH DIABETIC RETINOPATHY
Keywords:
Glaucoma, Diabetic Retinopathy, Intraocular Pressure, Blindness, HyperglycemiaAbstract
Relevance: Glaucoma and diabetic retinopathy (DR) are among the leading causes of irreversible blindness worldwide. Both conditions independently contribute to severe vision impairment, but their coexistence may accelerate progression to blindness. Understanding the interaction between these diseases is essential for improving patient outcomes.
Purpose: This study aims to assess the impact of glaucoma on the development of blindness in patients with DR, focusing on how elevated intraocular pressure (IOP) and systemic factors contribute to visual impairment. The goal is to identify key risk factors and suggest early intervention strategies.
Materials and Methods: A meta-analysis was conducted using data from observational studies on patients over 40 years old with both glaucoma and DR. Data included ophthalmic examinations, IOP measurements, and systemic health parameters (HbA1c, blood pressure). Literature from PubMed, Medline, and Scopus was analyzed to evaluate disease progression and the role of systemic and ocular factors.
Results: Patients with both glaucoma and DR experienced blindness significantly earlier (mean age 63.85 years) compared to those with only one condition. Hyperglycemia and elevated IOP were identified as critical contributors to visual deterioration. Male patients and those with poor glycemic control showed a higher prevalence of blindness, with open-angle glaucoma being the most common form in diabetic patients.
Conclusion: The coexistence of glaucoma and DR significantly accelerates the progression to blindness. Early detection, rigorous IOP management, and control of systemic conditions such as diabetes and hypertension are essential to prevent vision loss. These findings highlight the need for integrated clinical management strategies and regular screening in at-risk populations.
References
Allison, K., Patel, D., & Alabi, O. (2020). Epidemiology of Glaucoma: The Past, Present, and Predictions for the Future. Cureus, 12(11), e11686. https://doi.org/10.7759/cureus.11686
Almutairi, N. M., Alahmadi, S., Alharbi, M., Gotah, S., & Alharbi, M. (2021). The Association Between HbA1c and Other Biomarkers With the Prevalence and Severity of Diabetic Retinopathy. Cureus, 13(1), e12520. https://doi.org/10.7759/cureus.12520
Almutairi, N. M., Alahmadi, S., Alharbi, M., Gotah, S., & Alharbi, M. (2021). The Association Between HbA1c and Other Biomarkers With the Prevalence and Severity of Diabetic Retinopathy. Cureus, 13(1), e12520. https://doi.org/10.7759/cureus.12520
Beena, D., Senthilkumar, D.T., & Raja, D. (2017). Incidence of Glaucoma & Diabetic Retinopathy in Patients with Diabetes Mellitus in A Teaching Hospital.
Dharmadhikari, S., Lohiya, K., Chelkar, V., Kalyani, V. K., Dole, K., Deshpande, M., Khandekar, R., & Kulkarni, S. (2015). Magnitude and determinants of glaucoma in type II diabetics: A hospital based cross-sectional study in Maharashtra, India. Oman journal of ophthalmology, 8(1), 19–23. https://doi.org/10.4103/0974-620X.149858
Dorothea Peters, Boel Bengtsson, Anders Heijl, Lifetime Risk of Blindness in Open-Angle Glaucoma, American Journal of Ophthalmology, Volume 156, Issue 4, 2013, Pages 724-730, ISSN 0002-9394, https://doi.org/10.1016/j.ajo.2013.05.027.
Gillow, J. T., Gibson, J. M., & Dodson, P. M. (1999). Hypertension and diabetic retinopathy--what's the story?. The British journal of ophthalmology, 83(9), 1083–1087. https://doi.org/10.1136/bjo.83.9.1083
Hajar, S., Al Hazmi, A., Wasli, M., Mousa, A., & Rabiu, M. (2015). Prevalence and causes of blindness and diabetic retinopathy in Southern Saudi Arabia. Saudi medical journal, 36(4), 449–455. https://doi.org/10.15537/smj.2015.4.10371
Khandekar, R., & Zutshi, R. (2004). Glaucoma among Omani diabetic patients: a cross-sectional descriptive study: (Oman diabetic eye study 2002). European journal of ophthalmology, 14(1), 19–25. https://doi.org/10.1177/112067210401400104
Leasher JL, Bourne RR, Flaxman SR, Jonas JB, Keeffe J, Naidoo K, et al. (2016). Global estimates on the number of people blind or visually impaired by diabetic retinopathy: A meta-analysis from 1990 to 2010. Diabetes Care, 39(9), 1643-1649.
Nislawati, R., Taufik Fadillah Zainal, A., Ismail, A., Waspodo, N., Kasim, F., & Gunawan, A. M. A. K. (2021). Role of hypertension as a risk factor for open-angle glaucoma: a systematic review and meta-analysis. BMJ open ophthalmology, 6(1), e000798. https://doi.org/10.1136/bmjophth-2021-000798
Shrestha, P., Kaiti, R., & Shyangbo, R. (2022). Blindness among Patients with Type II Diabetes Mellitus Presenting to the Outpatient Department of Ophthalmology of a Tertiary Care Centre: A Descriptive Cross-sectional Study. JNMA; journal of the Nepal Medical Association, 60(254), 877–880. https://doi.org/10.31729/jnma.7702
Sun, Y., Chen, A., Zou, M., Zhang, Y., Jin, L., Li, Y., Zheng, D., Jin, G., & Congdon, N. (2022). Time trends, associations and prevalence of blindness and vision loss due to glaucoma: an analysis of observational data from the Global Burden of Disease Study 2017. BMJ open, 12(1), e053805. https://doi.org/10.1136/bmjopen-2021-053805
Tahani Emgory, & Anwar Gibril. (2024). Association Between Primary Open Angle Glaucoma and Type II Diabetes Mellitus in Benghazi, Libya. AlQalam Journal of Medical and Applied Sciences, 369–376. https://doi.org/10.54361/ajmas.2472024
Tahani Emgory, & Anwar Gibril. (2024). Association Between Primary Open Angle Glaucoma and Type II Diabetes Mellitus in Benghazi, Libya. AlQalam Journal of Medical and Applied Sciences, 369–376. https://doi.org/10.54361/ajmas.2472024
Tahani Emgory, & Anwar Gibril. (2024). Association Between Primary Open Angle Glaucoma and Type II Diabetes Mellitus in Benghazi, Libya. AlQalam Journal of Medical and Applied Sciences, 369–376. https://doi.org/10.54361/ajmas.2472024
Tahani Emgory, & Anwar Gibril. (2024). Association Between Primary Open Angle Glaucoma and Type II Diabetes Mellitus in Benghazi, Libya. AlQalam Journal of Medical and Applied Sciences, 369–376. https://doi.org/10.54361/ajmas.2472024
Vision Loss Expert Group of the Global Burden of Disease Study., the GBD 2019 Blindness and Vision Impairment Collaborators. Global estimates on the number of people blind or visually impaired by glaucoma: A meta-analysis from 2000 to 2020. Eye 38, 2036–2046 (2024). https://doi.org/10.1038/s41433-024-02995-5
